10-K/A

AMENDMENT #1 TO FORM 10-K

Company: Exousia Bio, Inc.
Filed: November 16, 2023
Period of Report: May 31, 2023
Accession Number: 0001683168-23-008224

View Document ↗ View on SEC.gov ↗